Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection

Journal of Rheumatology

Volumn 23, Issue 1, 1996, Pages 112-119

  Elling, Preben ^a   Olsson, Anders T ^b   Elling, Hanne ^b  

^a RANDERS REGIONAL HOSPITAL   (Denmark)

^b VIBORG HOSPITAL   (Denmark)

Author keywords

Cyclic fluctuations; Mycoplasma pneumoniae; Polymyalgia rheumatica; Temporal arteritis

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYCOPLASMA PNEUMONIAE; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; TEMPORAL ARTERITIS;

AGED; BIOPSY; DENMARK; DISEASE OUTBREAKS; HUMANS; INCIDENCE; MIDDLE AGED; MYCOPLASMA INFECTIONS; MYCOPLASMA PNEUMONIAE; PERIODICITY; POLYMYALGIA RHEUMATICA; TEMPORAL ARTERITIS;

EID: 0030066029     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Bacon PA, Doherty SM, Zuckerman AJ: Hepatitis-B antibody in polymyalgia rheumatica. Lancet 1975;2:476-8.
2. Elling H, SkinhøJ P, Elling P Hepatitis B virus and polymyalgia rheumatica Ann Rheum Dis 1980;30:511-3.
3. Cimmino MA, Grazi G, Balistreri M, Accardo S: Increased prevalence of antibodies to adenovirus and respiratory syncytial virus in polymyalgia rheumatica. Clin Exp Rheumatol 1993;11:309-13.
4. Russo MG, Waxman J, Abdoh AA, Serebro LH: Correlation between infection and the onset of the giant cell (temporal) arteritis syndrome. Arthritis Rheum 1995;38:374-80.
5. Grunewald J, Anderson R, Rydberg I, et al: CD4+ and CD8+ T cell expansions using selected TCR V and J gene segments at the onset of giant cell arteritis Arthritis Rheum 1994;37:1221-7.
6. Martinez-Taboada VM, Turner K, Hunder GG, Goronzy JJ, Weyand CM: Steroid responsive CD8 clonotypes in polymyalgia rheumatica and giant cell arteritis (abstr). Arthritis Rheum 1994;(suppl)37:S637.
7. Bengtsson B-A, Malmvall B-E: The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Arthritis Rheum 1981;24:899-904.
8. Huston KA, Hunder GG, Stanson AW, Sheps SG: Temporal arteritis: A 25 year epidcmiological, clinical and pathologic study. Ann Intern Med 1978;88:162-7.
9. Machado EBV, Michet CJ, Ballard DJ, et al. Trends in incidence and clinical presentation of temporal arteritis in Olmsted county, Minnesota, 1950 1985. Arthritis Rheum 1988;31:745-9.
10. Chuang T-Y, Hunder GG, Ilstrup DM, Kurland LT: Polymyalgia rheumatica, a 10-year epidemiologic and clinical study. Ann Intern Med 1952,97:672-80.
11. Boesen P, Sørensen SF: Giant cell arteritis, temporal arteritis and polymyalgia rheumatica in a Danish county. Arthritis Rheum 1987;30:294-9.
12. Delecoeuillerie G, Joly P, De Lara AC, Paolaggi JB: Polymyalgia rheumatica and temporal arteritis. A retrospective analysis of prognostic features and different corticosteroid regimes (11 year survey of 210 patients). Ann Rheum Dis 1988,47:733-9.
13. Salvarani C, Macchioni PL, Tartoni PL, et al: Polymyalgia rheumatica and giant cell arteritis: A 5-year epidemiologic and clinical study in Reggio Emilia, Italy. Clin Exp Rheumatol 1987;5:205-15.
14. Gonzalez MA, Alonso MD, Aguero JJ, Bal M, Femandez-Camblor B, Sanchez-Andrade A: Temporal arteritis in a northwestern area of Spain: Study of 57 biopsy proven patients. J Rheumatol 1992;19:277-80.
15. Fainaru M, Friedman G, Friedman B: Temporal arteritis in Israel. A review of 47 patients. J Rheumatol 1979;6:330-5.
16. Baethge BA, Brodwick MS, Lisse JR, Goowin JS: Polymyalgia rheumatica and giant cell arteritis in different ethnic/racial groups (abstr). Clin Exp Rheumatol 1987;5:134.
17. Lind K: Manifestations and complications of Mycoplasma pneumoniae disease. Yale J Biol Meet 1983;56:46l-8.
18. Cassell GH, Barry CC: Mycoplasmas as agents of human disease. N Engl J Med 1981;304:80-9.
19. Lind K, Bentzon MW: Changes in the epidemiological pattern of Mycoplasma pneumoniae infections in Denmark. Epidem Infect 1988;101:377-86.
20. Ruuth E, Praz F: Interaction between Mycoplasmas and the immune system Immunol Rev 1989;112:133-60.
21. Thomas L: Expenmental mycoplasma infections as models of rheumatoid arthritis. Fed Proc 1973;32:143-6.
22. Finkel TH, Torok TJ, Ferguson PJ, et al: Chronic parvovirus B19 infection and systemic necrotising vasculitis: Opportunistic infection or aetiological agent? Lancet 1994;343:1255-8.
23. Ellis ME, Ralston WS: The ESR in diagnosis of the polymyalgia rheumatica/giant cell arteritis syndrome. Ann Rheum Dis 1983;42:168-70.
24. Lind K, Bentzon MW: Ten and a half years seroepidemiology of Mycoplasma pneumoniae infection in Denmark. Epidem Infect 1991,107:189-99.
25. Salvarani C, Gabriel SF, O'Fallon M, Hunder GG: The incidence of giant cell arteritis in Olmsted county, Minnesota, apparent fluctuations in a cyclic pattern (abstr). Ann Int Med 1995; 123:192-4.
26. Nordborg E. Bengtsson BA: Epidemiology of biopsy-proven giant cell arteritis. J Intern Med 1990;227:233-6.